RxDoctor Payments Data

David Kasanoff

Optometrist · la Mesa, CANPI 1114093622

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $131,351 of the $141,295 with a category attached, or 93.0%. Topcon Healthcare, Inc. accounts for 97.0% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2022 at $85,180 and has fallen 98.0% since, to $1,713 in 2025. Among optometrist clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$141,295in general payments, 2019–2025

Across 130 payments — averaging $1086.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Topcon Healthcare, Inc.$137K
  • Heidelberg Engineering, Inc.$680
  • Coopervision Inc.$651
  • Tarsus Pharmaceuticals, Inc.$575
  • Alcon$500
  • Glaukos Corporation$320
  • plus $1K from 10 others
$904,086in research payments, 2019–2025

Across 53 payments — averaging $17,058 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Topcon Healthcare, Inc.$904K

What the payments were for

  • Consulting fees$131,35193%
  • Speaking & faculty fees$5000%
  • Travel & lodging$1,0261%
  • Food & beverage$8,3036%
  • Gifts$190%
  • Entertainment$950%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$141,295 in reported general payments places this provider in the 95th percentile of 6,778 optometrist providers in California.

See all optometrist providers in California

Medicare billing

Part B allowed, 2024
$6,974
Medicare patients
38
Services billed
72

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost14$71

Paid to pharmacies, not to this prescriber.

Other optometrist in la Mesa

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →